FindTrial
Sign In

Establishment of Nation-wide Sjogren's Syndrome Cohort and Development of Theragnosis

Establishment of Nation-wide Sjogren's Syndrome Cohort and Development of Theragnosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001099
Enrollment
500
Registered
2014-05-08
Start date
2013-10-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who fulfill the American College of Rheumatology [ACR]/ the European league against rheumatism [EULAR] criteria for Sjogren's syndrome which was revised in 2002 and/or 2012 ACR criteria. 2) Patients who agree to be enrolled in pSS cohort by informed consent.

Exclusion criteria

Exclusion criteria: We excluded participants with rheumatoid arthritis, systemic lupus erythematosus, scleroderma, or other connective tissue disease. Any patient with prior diagnosis of any of the following conditions is excluded: History of head and neck radiation treatment Hepatitis C infection Acquired immunode?ciency syndrome Sarcoidosis Amyloidosis Graft versus host disease IgG4-related disease

Design outcomes

Primary

MeasureTime frame
Disease activity (ESSDAI, ESSPRI) Damage index (SSDDI) QoL(EQ5D)—

Secondary

MeasureTime frame
Clinical manifestation, Degree of fullfillment of Classification criteria—

Countries

Korea, Republic of

Contacts

Public ContactJennifer Lee

The Catholic University of Korea, Seoul St. Mary's Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026